Dr. Ana Mihalcea on self-amplifying mRNA vaccine against COVID-19

"We know that these replicon vaccines, so for example, the presidential budget on nanotechnology specifically discussed that the development of replicon vaccines in the United States was a priority for this year. And there are Ebola HIV platforms, there are all of these biological weapons systems that already have been design, there's already literature on this. And so if you are then deploying this again and this stuff sheds, so the shedding process means it's transmissible from person to person. It can potentially also affect, you know, again, animals, et cetera, then you have a biological warfare scenario that of huge proportions."